跳至主要内容
临床试验/ITMCTR1900002724
ITMCTR1900002724招募中1 期

Based on the theory of cold and hot, the immune mechanism of treating vitiligo by activating il-33 /ST2 signaling pathway with fire needle was studied

Xinjiang Uygur Autonomous Region Academy of Chinese Medical0 个研究点开始时间: 待定最近更新:
适应症

试验速览

阶段
1 期
状态
招募中
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional study

入排标准

年龄范围
18 至 65(—)
性别
All

入选标准

  • (1) aged 18 to 65 years, men and women;
  • (2) in line with the clinical diagnostic criteria of vitiligo vulgaris;
  • (3) skin loss area <= 10% of the surface area;
  • (4) voluntary participation, signed informed consent.

排除标准

  • (1) special parts (hair, eyes, vulva) with skin lesions;
  • (2) the site of damage or infected;
  • (3) scar constitution, dizzy or extremely afraid of fire needles;
  • (4) nearly 1 month system used to treat vitiligo drugs or glucocorticoid drugs;
  • (5) complicated with serious cardiovascular and cerebrovascular diseases, liver and kidney system diseases;
  • (6) hemophilia, coagulation dysfunction or bleeding prone patients;
  • (7) mental patients and pregnant women, nursing patients;
  • (8) add patients in other clinical trials within 3 months;
  • (9) patients with skin tumors.

研究者

发起方
Xinjiang Uygur Autonomous Region Academy of Chinese Medical

相似试验